Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B

Pediatr Blood Cancer. 2007 Dec;49(7):987-9. doi: 10.1002/pbc.21300.

Abstract

Niemann-Pick type B (NP) is an autosomal recessive lysosomal storage disorder with variable phenotypes for which few patients have undergone hematopoietic progenitor cell (HPC) transplantation. We present an 18-month old with NP type B who underwent two allogeneic HPC transplants from her HLA-identical sister. Sphingomyelinase in the peripheral leucocytes and skin fibroblasts was absent at diagnosis. Engraftment failed following initial transplant; therefore a second with the same donor was performed. Engraftment since has been durable; all subsequent sphingomyelinase levels have been normal. Our experience indicates that HPC transplantation for patients with NP type B is feasible and beneficial.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow Transplantation
  • Cells, Cultured
  • Female
  • Fibroblasts / enzymology
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Infant
  • Leukocytes, Mononuclear / enzymology
  • Niemann-Pick Disease, Type B / diagnosis
  • Niemann-Pick Disease, Type B / enzymology*
  • Niemann-Pick Disease, Type B / therapy*
  • Siblings
  • Sphingomyelin Phosphodiesterase / analysis*
  • Transplantation Conditioning* / adverse effects
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Sphingomyelin Phosphodiesterase